US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GRAIL, Inc.

100.07

+6.016.39%

Post-market: 99.10-0.9700-0.97%19:59 EST

Volume:724.08K

Turnover:72.04M

Market Cap:3.90B

PE:-8.61

High:101.01

Open:98.30

Low:96.75

Close:94.06

52wk High:118.84

52wk Low:20.44

Shares:38.98M

Float Shares:31.06M

Volume Ratio:0.99

T/O Rate:2.33%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-11.6175

EPS(LYR):-63.5400

ROE:-16.83%

ROA:-11.07%

PB:1.74

PE(LYR):-1.57

Loading ...

Overview Company News Filings

Hims & Hers Is Offering a New Cancer Test. It May Not Be Ready for Prime Time. -- Barrons.com

Hims & Hers Health kooperiert mit GRAIL für Multi-Krebs-Früherkennungstest

Grail submits FDA premarket approval appplication for Galleri

Grail Submits FDA Premarket Approval Application for Galleri Multi-Cancer Early Detection Test

Grail Is Maintained at Buy by Guggenheim

Grail falls -9.2%

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and GRAIL Inc (GRAL)

Morgan Stanley sees ‘nothing thesis changing’ in Grail results

Grail sees 2025 revenue $147M-$148M, consensus $145.75M

Grail Inc. to Present at J.P. Morgan Healthcare Conference

Grail Inc. CFO Aaron Freidin Reports Disposal of Common Shares

Grail Is Maintained at Equal-Weight by Morgan Stanley

Morgan Stanley Raises Price Target on GRAIL to $110 From $85, Keeps Equalweight Rating

MT Newswires Live

Grail Grants RSUs to New Employees Under Inducement Equity Plan

Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Will GRAIL's (GRAL) Swift Capital Raise Redefine Its Approach to Funding Growth?

Simply Wall St.

Illumina Reports Disposal of Grail Inc. Common Shares

Grail Inc. to Present at Piper Sandler 37th Annual Healthcare Conference

Grail falls -9.3%

Stock Track | GRAIL Soars 5.22% as Canaccord Genuity Maintains Buy Rating and Boosts Price Target

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GRAL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GRAL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","market":"US","secType":"STK","nameCN":"GRAIL, Inc.","latestPrice":100.07,"timestamp":1770411600000,"preClose":94.06,"halted":0,"volume":724079,"hourTrading":{"tag":"盘后","latestPrice":99.1,"preClose":100.07,"latestTime":"19:59 EST","volume":4428,"amount":442537.12,"timestamp":1770425972978,"change":-0.97,"changeRate":-0.009693,"amplitude":0.009693},"delay":0,"changeRate":0.06389538592387828,"floatShares":31063800,"shares":38982223,"eps":-11.617467,"marketStatus":"Market Closed","change":6.01,"latestTime":"02-06 16:00:00 EST","open":98.3,"high":101.01,"low":96.75,"amount":72041226.3944,"amplitude":0.04529,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.617467,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":94.06,"preHourTrading":{"tag":"盘前","latestPrice":98.39,"preClose":94.06,"latestTime":"09:28 EST","volume":1392,"amount":134023.37472,"timestamp":1770388083073,"change":4.33,"changeRate":0.046034,"amplitude":0.037317},"postHourTrading":{"tag":"盘后","latestPrice":99.1,"preClose":100.07,"latestTime":"19:59 EST","volume":4428,"amount":442537.12,"timestamp":1770425972978,"change":-0.97,"changeRate":-0.009693,"amplitude":0.009693},"volumeRatio":0.9938339689920476,"impliedVol":0.8426,"impliedVolPercentile":0.1195},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GRAL\",,,,,undefined,":{"symbol":"GRAL","floatShares":31063800,"roa":"-11.07%","roe":"-16.83%","lyrEps":-63.539968,"volumeRatio":0.9938339689920476,"shares":38982223,"dividePrice":0,"high":101.01,"amplitude":0.04529,"preClose":94.06,"low":96.75,"week52Low":20.44,"pbRate":"1.74","psRate":"27.50","week52High":118.84,"institutionHeld":0,"latestPrice":100.07,"eps":-11.617467,"divideRate":0,"volume":724079,"delay":0,"ttmEps":-11.617467,"open":98.3,"prevYearClose":85.59,"prevWeekClose":97.82,"prevMonthClose":97.82,"prevQuarterClose":85.59,"fiveDayClose":97.82,"twentyDayClose":98.04,"sixtyDayClose":85.11},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GRAL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"GRAL","fiscalQuarterEnding":"2025/09","expectedEps":-3.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-2.46},{"market":"US","date":"2025-08-12","symbol":"GRAL","fiscalQuarterEnding":"2025/06","expectedEps":-3.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-3.18},{"market":"US","date":"2025-05-13","symbol":"GRAL","fiscalQuarterEnding":"2025/03","expectedEps":-4.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-3.1},{"market":"US","date":"2025-02-20","symbol":"GRAL","fiscalQuarterEnding":"2024/12","expectedEps":-4.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"post","actualEps":-1.86},{"market":"US","date":"2024-11-12","symbol":"GRAL","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-3.94}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GRAL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GRAL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1763010000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GRAL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GRAL","date":"2026-02-06","current":-8.613754,"percent":0.092308,"low":-11.136928,"twenty":-5.92371,"median":-0.62862,"eighty":-0.266328,"high":-0.135365,"avg":-2.439794,"sd":3.331716,"marketCap":3666667895},"quantilePoints":[{"date":"2024-06-12","current":-0.243184,"twenty":-0.243184,"median":-0.243184,"eighty":-0.243184,"marketCap":362571424},{"date":"2024-06-28","current":-0.269888,"twenty":-0.264547,"median":-0.256536,"eighty":-0.248525,"marketCap":402385270},{"date":"2024-07-05","current":-0.275763,"twenty":-0.275763,"median":-0.271757,"eighty":-0.266328,"marketCap":411144316},{"date":"2024-07-12","current":-0.259385,"twenty":-0.273627,"median":-0.266328,"eighty":-0.249504,"marketCap":386725157},{"date":"2024-07-15","current":-0.263657,"twenty":-0.273022,"median":-0.264992,"eighty":-0.25148,"marketCap":393095372},{"date":"2024-08-02","current":-0.296236,"twenty":-0.274909,"median":-0.266328,"eighty":-0.253456,"marketCap":441668264},{"date":"2024-08-09","current":-0.310656,"twenty":-0.300615,"median":-0.272114,"eighty":-0.260667,"marketCap":463167741},{"date":"2024-08-16","current":-0.170902,"twenty":-0.29588,"median":-0.2706,"eighty":-0.248276,"marketCap":492749978},{"date":"2024-08-23","current":-0.178117,"twenty":-0.292284,"median":-0.264992,"eighty":-0.180551,"marketCap":513552907},{"date":"2024-08-30","current":-0.159595,"twenty":-0.28292,"median":-0.259385,"eighty":-0.170708,"marketCap":460148373},{"date":"2024-09-06","current":-0.145057,"twenty":-0.275763,"median":-0.247457,"eighty":-0.162201,"marketCap":418232023},{"date":"2024-09-13","current":-0.145918,"twenty":-0.275336,"median":-0.18151,"eighty":-0.152854,"marketCap":420715955},{"date":"2024-09-20","current":-0.149365,"twenty":-0.273627,"median":-0.178117,"eighty":-0.150075,"marketCap":430651682},{"date":"2024-09-27","current":-0.146457,"twenty":-0.273022,"median":-0.170741,"eighty":-0.146026,"marketCap":422268412},{"date":"2024-10-04","current":-0.135365,"twenty":-0.270458,"median":-0.165733,"eighty":-0.14454,"marketCap":390287790},{"date":"2024-10-11","current":-0.140319,"twenty":-0.269176,"median":-0.160133,"eighty":-0.142925,"marketCap":404570398},{"date":"2024-10-18","current":-0.152918,"twenty":-0.265794,"median":-0.156041,"eighty":-0.143463,"marketCap":440897901},{"date":"2024-10-25","current":-0.13978,"twenty":-0.263443,"median":-0.155556,"eighty":-0.143463,"marketCap":403017941},{"date":"2024-10-31","current":-0.146672,"twenty":-0.262589,"median":-0.153942,"eighty":-0.142688,"marketCap":422889395},{"date":"2024-11-08","current":-0.160456,"twenty":-0.259385,"median":-0.152918,"eighty":-0.142796,"marketCap":462632305},{"date":"2024-11-15","current":-0.250879,"twenty":-0.250879,"median":-0.154641,"eighty":-0.143442,"marketCap":531228205},{"date":"2024-11-22","current":-0.259924,"twenty":-0.250879,"median":-0.156041,"eighty":-0.143549,"marketCap":550380645},{"date":"2024-11-29","current":-0.277697,"twenty":-0.262044,"median":-0.156472,"eighty":-0.143635,"marketCap":588013510},{"date":"2024-12-06","current":-0.355611,"twenty":-0.27003,"median":-0.160025,"eighty":-0.14426,"marketCap":752993300},{"date":"2024-12-13","current":-0.329745,"twenty":-0.275763,"median":-0.161318,"eighty":-0.144928,"marketCap":698224042},{"date":"2024-12-20","current":-0.271984,"twenty":-0.27776,"median":-0.165841,"eighty":-0.145746,"marketCap":575917232},{"date":"2024-12-27","current":-0.308005,"twenty":-0.287312,"median":-0.170741,"eighty":-0.145918,"marketCap":652190984},{"date":"2025-01-03","current":-0.284362,"twenty":-0.289787,"median":-0.175532,"eighty":-0.146134,"marketCap":602125834},{"date":"2025-01-10","current":-0.280236,"twenty":-0.294514,"median":-0.180594,"eighty":-0.1465,"marketCap":593389633},{"date":"2025-01-17","current":-0.276189,"twenty":-0.293978,"median":-0.222157,"eighty":-0.146801,"marketCap":584821436},{"date":"2025-01-24","current":-0.412102,"twenty":-0.295346,"median":-0.234852,"eighty":-0.147318,"marketCap":872612048},{"date":"2025-01-31","current":-0.500013,"twenty":-0.298484,"median":-0.241319,"eighty":-0.14818,"marketCap":1058760325},{"date":"2025-02-07","current":-0.523498,"twenty":-0.307212,"median":-0.249504,"eighty":-0.148826,"marketCap":1108489468},{"date":"2025-02-14","current":-0.83436,"twenty":-0.31102,"median":-0.255132,"eighty":-0.149365,"marketCap":1766728591},{"date":"2025-02-21","current":-0.791697,"twenty":-0.321747,"median":-0.260916,"eighty":-0.149365,"marketCap":1604772870},{"date":"2025-02-28","current":-0.656882,"twenty":-0.34371,"median":-0.263657,"eighty":-0.149709,"marketCap":1331502572},{"date":"2025-03-07","current":-0.559345,"twenty":-0.359577,"median":-0.270244,"eighty":-0.149795,"marketCap":1133795978},{"date":"2025-03-14","current":-0.450152,"twenty":-0.414561,"median":-0.273627,"eighty":-0.15014,"marketCap":912460022},{"date":"2025-03-21","current":-0.465034,"twenty":-0.450921,"median":-0.275763,"eighty":-0.150484,"marketCap":942626791},{"date":"2025-03-28","current":-0.47791,"twenty":-0.468947,"median":-0.276427,"eighty":-0.150807,"marketCap":968726130},{"date":"2025-04-04","current":-0.416039,"twenty":-0.465703,"median":-0.277856,"eighty":-0.15113,"marketCap":843313720},{"date":"2025-04-11","current":-0.380338,"twenty":-0.459122,"median":-0.280236,"eighty":-0.151281,"marketCap":770947370},{"date":"2025-04-17","current":-0.443129,"twenty":-0.455455,"median":-0.281347,"eighty":-0.151562,"marketCap":898224019},{"date":"2025-04-25","current":-0.630246,"twenty":-0.466372,"median":-0.283965,"eighty":-0.151863,"marketCap":1277511821},{"date":"2025-05-02","current":-0.565758,"twenty":-0.478944,"median":-0.287218,"eighty":-0.15253,"marketCap":1146794916},{"date":"2025-05-09","current":-0.62862,"twenty":-0.498389,"median":-0.292296,"eighty":-0.15337,"marketCap":1274216573},{"date":"2025-05-16","current":-0.732698,"twenty":-0.51302,"median":-0.295346,"eighty":-0.153995,"marketCap":1402606531},{"date":"2025-05-23","current":-0.728564,"twenty":-0.527433,"median":-0.296725,"eighty":-0.154728,"marketCap":1394692362},{"date":"2025-05-30","current":-0.772349,"twenty":-0.542338,"median":-0.298484,"eighty":-0.155417,"marketCap":1478510603},{"date":"2025-06-06","current":-0.742094,"twenty":-0.562722,"median":-0.305137,"eighty":-0.155977,"marketCap":1420593278},{"date":"2025-06-13","current":-0.787758,"twenty":-0.602918,"median":-0.308322,"eighty":-0.156041,"marketCap":1508008868},{"date":"2025-06-20","current":-0.910282,"twenty":-0.617043,"median":-0.310838,"eighty":-0.156127,"marketCap":1742556049},{"date":"2025-06-27","current":-0.927946,"twenty":-0.628237,"median":-0.313683,"eighty":-0.156967,"marketCap":1776371133},{"date":"2025-07-03","current":-0.87796,"twenty":-0.640897,"median":-0.324667,"eighty":-0.158949,"marketCap":1680681639},{"date":"2025-07-11","current":-0.815382,"twenty":-0.656882,"median":-0.33641,"eighty":-0.159595,"marketCap":1560889904},{"date":"2025-07-18","current":-0.675007,"twenty":-0.694504,"median":-0.351643,"eighty":-0.160456,"marketCap":1292167904},{"date":"2025-07-25","current":-0.746416,"twenty":-0.703946,"median":-0.35847,"eighty":-0.160672,"marketCap":1428867181},{"date":"2025-08-01","current":-0.642872,"twenty":-0.704698,"median":-0.372061,"eighty":-0.161318,"marketCap":1230653229},{"date":"2025-08-08","current":-0.619382,"twenty":-0.703946,"median":-0.384644,"eighty":-0.164764,"marketCap":1185686362},{"date":"2025-08-15","current":-2.618835,"twenty":-0.718416,"median":-0.412102,"eighty":-0.165733,"marketCap":1160018171},{"date":"2025-08-22","current":-2.697774,"twenty":-0.721799,"median":-0.415789,"eighty":-0.165949,"marketCap":1194984536},{"date":"2025-08-29","current":-2.7759,"twenty":-0.732698,"median":-0.419718,"eighty":-0.170579,"marketCap":1229590423},{"date":"2025-09-05","current":-2.733582,"twenty":-0.742958,"median":-0.427076,"eighty":-0.170837,"marketCap":1210845568},{"date":"2025-09-12","current":-3.145369,"twenty":-0.751941,"median":-0.435395,"eighty":-0.172539,"marketCap":1393247431},{"date":"2025-09-19","current":-3.221867,"twenty":-0.757193,"median":-0.443129,"eighty":-0.177083,"marketCap":1427132362},{"date":"2025-09-26","current":-3.927439,"twenty":-0.772199,"median":-0.450236,"eighty":-0.179927,"marketCap":1739666779},{"date":"2025-10-03","current":-5.267781,"twenty":-0.790326,"median":-0.453995,"eighty":-0.180724,"marketCap":2333374029},{"date":"2025-10-10","current":-5.788618,"twenty":-0.792794,"median":-0.466707,"eighty":-0.18193,"marketCap":2564079942},{"date":"2025-10-17","current":-7.032117,"twenty":-0.810572,"median":-0.474733,"eighty":-0.214168,"marketCap":3114890311},{"date":"2025-10-24","current":-6.726125,"twenty":-0.834423,"median":-0.483801,"eighty":-0.232186,"marketCap":2979350587},{"date":"2025-10-31","current":-7.417862,"twenty":-0.86879,"median":-0.497307,"eighty":-0.23482,"marketCap":3285756878},{"date":"2025-11-07","current":-6.515349,"twenty":-0.90953,"median":-0.508594,"eighty":-0.23627,"marketCap":2885986787},{"date":"2025-11-14","current":-7.32206,"twenty":-1.284423,"median":-0.515869,"eighty":-0.238888,"marketCap":3243320953},{"date":"2025-11-21","current":-8.218834,"twenty":-2.622741,"median":-0.524768,"eighty":-0.242438,"marketCap":3338827399},{"date":"2025-11-28","current":-10.592844,"twenty":-2.668803,"median":-0.533066,"eighty":-0.245748,"marketCap":4303247596},{"date":"2025-12-05","current":-10.047321,"twenty":-2.733908,"median":-0.545714,"eighty":-0.248685,"marketCap":4081633659},{"date":"2025-12-12","current":-9.121802,"twenty":-2.773947,"median":-0.559678,"eighty":-0.249586,"marketCap":3705650118},{"date":"2025-12-19","current":-8.474563,"twenty":-3.023948,"median":-0.565758,"eighty":-0.250383,"marketCap":3442715024},{"date":"2025-12-26","current":-8.814736,"twenty":-3.115583,"median":-0.600672,"eighty":-0.254281,"marketCap":3580907004},{"date":"2026-01-02","current":-8.213077,"twenty":-3.191837,"median":-0.607471,"eighty":-0.259493,"marketCap":3336488466},{"date":"2026-01-09","current":-9.407758,"twenty":-3.756539,"median":-0.615248,"eighty":-0.260321,"marketCap":3821817142},{"date":"2026-01-16","current":-9.350183,"twenty":-4.63773,"median":-0.618067,"eighty":-0.262044,"marketCap":3798427809},{"date":"2026-01-23","current":-11.136928,"twenty":-5.050494,"median":-0.621638,"eighty":-0.262589,"marketCap":4524276801},{"date":"2026-01-30","current":-9.689876,"twenty":-5.381714,"median":-0.623725,"eighty":-0.263657,"marketCap":3936424878},{"date":"2026-02-06","current":-9.025844,"twenty":-5.92371,"median":-0.62862,"eighty":-0.266328,"marketCap":3666667895}],"updateTime":1770483098012},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GRAL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609753512","title":"Hims & Hers Is Offering a New Cancer Test. It May Not Be Ready for Prime Time. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2609753512","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609753512?lang=en_us&edition=fundamental","pubTime":"2026-02-07 06:41","pubTimestamp":1770417660,"startTime":"0","endTime":"0","summary":"A new Super Bowl ad from Hims & Hers is giving some medical experts pause. In addition to touting the company's weight loss drugs and testosterone treatments, it promotes a controversial early cancer detection test.Hims & Hers charges $689 for the test, which involves a blood draw and a prescription by a medical professional. It isn't approved by the Food and Drug Administration, nor is it covered by Medicare and most health insurance plans. However, the test's manufacturer, Grail, recently applied for premarket approval for it from the FDA and new federal legislation creates a pathway for Medicare coverage.The test, known as the Galleri multi-cancer early detection  test, promises to detect up to 50 different cancers before symptoms appear. Exact Sciences, maker of the colon cancer screening test Cologuard, released a competing product called Cancerguard last fall for $89, while Cancer Check Labs offers one that screens for some 200 kinds of cancers for $1,995.This content was created","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4585","LU1861558580.USD","BK4196","BK4139","GRAL","BK4588","LU1861559042.SGD","LU2324357040.USD","HIMS","LU0266013472.USD"],"gpt_icon":1},{"id":"2608367107","title":"Hims & Hers Health kooperiert mit GRAIL für Multi-Krebs-Früherkennungstest","url":"https://stock-news.laohu8.com/highlight/detail?id=2608367107","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608367107?lang=en_us&edition=fundamental","pubTime":"2026-02-04 22:01","pubTimestamp":1770213663,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hims & Hers Health Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"74060e00a21b1d65e69f351ee867338d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDLc6CHyP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GRAL","BK4139","HIMS"],"gpt_icon":1},{"id":"2607635540","title":"Grail submits FDA premarket approval appplication for Galleri","url":"https://stock-news.laohu8.com/highlight/detail?id=2607635540","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607635540?lang=en_us&edition=fundamental","pubTime":"2026-01-30 08:35","pubTimestamp":1769733319,"startTime":"0","endTime":"0","summary":"GRAIL (GRAL) “announced the submission of the final module of the Premarket Approval application to the U.S. Food and Drug Administration for its G...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-submits-fda-premarket-approval-appplication-for-galleri-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-submits-fda-premarket-approval-appplication-for-galleri-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2607068956","title":"Grail Submits FDA Premarket Approval Application for Galleri Multi-Cancer Early Detection Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2607068956","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607068956?lang=en_us&edition=fundamental","pubTime":"2026-01-30 08:25","pubTimestamp":1769732714,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. has submitted the final module of its Premarket Approval  application to the U.S. Food and Drug Administration  for the Galleri multi-cancer early detection  test. The Galleri test, which was designated as a Breakthrough Device by the FDA in 2018, aims to improve early cancer detection. The PMA submission is based on test performance and safety data from 25,490 participants in the US-based PATHFINDER 2 study and the first year of the NHS-Galleri trial. A bridging analysis comparing different versions of the Galleri test was also included to support the application.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via PR Newswire  on January 30, 2026, a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL558T3T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2606242930","title":"Grail Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2606242930","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606242930?lang=en_us&edition=fundamental","pubTime":"2026-01-27 00:46","pubTimestamp":1769445960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 26, 2026 11:46 ET (16:46 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2605794409","title":"Grail falls -9.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605794409","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605794409?lang=en_us&edition=fundamental","pubTime":"2026-01-23 23:05","pubTimestamp":1769180737,"startTime":"0","endTime":"0","summary":"Grail (GRAL) is down -9.2%, or -$10.68 to $105.39. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-falls-9-2-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-falls-9-2-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2603243632","title":"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and GRAIL Inc (GRAL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2603243632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603243632?lang=en_us&edition=fundamental","pubTime":"2026-01-14 03:10","pubTimestamp":1768331418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD – Research Report) and GRAIL I...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-and-grail-inc-gral-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-and-grail-inc-gral-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2324357040.USD","XLV","BK4585","BK4139","BK4137","IE00BSNM7G36.USD","BK4578","LU1066051498.USD","LU0128526141.USD","BK4568","BK4550","LU2468319806.SGD","IE00B19Z3581.USD","LU1839511570.USD","LU0114720955.EUR","LU1585245621.USD","LU1571399168.USD","LABU","XBI","LU1674673691.USD","IE00B19Z3B42.SGD","SG9999015986.USD","LU0289739699.SGD","LU2089984988.USD","LU2087621335.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","BK4581","GRAL","LU0889565916.HKD","LU0234570918.USD","LU1674673428.USD","HCSG","SG9999015952.SGD","IE00B3T34201.USD","BK4583","SG9999015978.USD","BK4588","IE00BKVL7J92.USD","BK4566","BK4532","LU1430594728.SGD","IE0002270589.USD","LU1066053197.SGD","SG9999015945.SGD","LU0823416689.USD","LU0882574055.USD","GILD","LU0109394709.USD","IE00B7SZLL34.SGD"],"gpt_icon":0},{"id":"2603528266","title":"Morgan Stanley sees ‘nothing thesis changing’ in Grail results","url":"https://stock-news.laohu8.com/highlight/detail?id=2603528266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603528266?lang=en_us&edition=fundamental","pubTime":"2026-01-13 02:45","pubTimestamp":1768243519,"startTime":"0","endTime":"0","summary":"Morgan Stanley says Grail’s (GRAL) preliminary Q4 results contain “nothing thesis changing.” The firm keeps an Equal Weight rating on the shares wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/morgan-stanley-sees-nothing-thesis-changing-in-grail-results-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/morgan-stanley-sees-nothing-thesis-changing-in-grail-results-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2089284900.SGD","LU1244550577.SGD","LU1162221912.USD","GRAL","LU0158827948.USD","LU1363072403.SGD","LU0912757837.SGD","LU0882574139.USD","LU1244550494.USD","LU1668664300.SGD","LU1732799900.SGD","LU0225283273.USD","BK4585","BK4588","BK4127","LU2028103732.USD","LU1732800096.USD","LU2347655156.SGD","LU1791710400.SGD","LU0106261372.USD","LU1791710582.SGD","BK4516","BK4581","LU1244550221.USD","LU0314104364.USD","LU2133065610.SGD","LU0795875086.SGD","LU0267386448.USD","IE00BKVL7J92.USD","LU1548497426.USD","IE00BZ1G4Q59.USD","LU0971096721.USD","LU2023251221.USD","LU1989772840.SGD","LU1720051017.SGD","LU2271345857.HKD","BK4534","LU0106831901.USD","BK4504","BK4139","LU0158827781.USD","LU0557290698.USD","MS","LU2357305700.SGD","LU0006306889.USD","LU0098860793.USD","LU1074936037.SGD","LU0320765646.SGD","LU1720051108.HKD","LU0795875169.SGD"],"gpt_icon":0},{"id":"2603445385","title":"Grail sees 2025 revenue $147M-$148M, consensus $145.75M","url":"https://stock-news.laohu8.com/highlight/detail?id=2603445385","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603445385?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:45","pubTimestamp":1768232739,"startTime":"0","endTime":"0","summary":"The company sees 2025 cash burn $274M vs. $597M in 2024. Grail (GRAL) issued guidance in JPMorgan healthcare conference presentation slides. Publis...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-sees-2025-revenue-147m-148m-consensus-145-75m-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-sees-2025-revenue-147m-148m-consensus-145-75m-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930490.SGD","LU2756315664.SGD","IE00BYXW3230.USD","BK4581","IE00BFXG1179.USD","LU1116320737.USD","LU2211815571.USD","LU2381873111.SGD","LU1064131342.USD","LU2417539215.USD","LU0820562030.AUD","IE00BZ1G4Q59.USD","LU2054465674.USD","LU1366192091.USD","LU0211326755.USD","LU0323591593.USD","LU2236285917.USD","LU1720051108.HKD","LU1720051017.SGD","LU0203345920.USD","LU1244550494.USD","LU1363072403.SGD","BK4534","LU0048584097.USD","LU0106831901.USD","LU0345769631.USD","SG9999002224.SGD","LU1261432733.SGD","LU0211331839.USD","IE00BKDWB100.SGD","LU1116320901.HKD","LU2552382215.SGD","IE00BKVL7J92.USD","IE0034235303.USD","LU0882574139.USD","LU1551013342.USD","LU2023250330.USD","LU1280957306.USD","LU0234572021.USD","LU0942090050.USD","LU0265550946.USD","IE0034235295.USD","LU0251132253.USD","LU0149725797.USD","LU0787776722.HKD","LU1496350171.SGD","LU1244550221.USD","GRAL","LU0106261372.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2591621295","title":"Grail Inc. to Present at J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2591621295","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591621295?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:01","pubTimestamp":1765832481,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12 at 7:30 a.m. PT. The presentation will be available via live and replay webcasts on the investor relations section of GRAIL's website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via PR Newswire  on December 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL9ypJ5m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2589381700","title":"Grail Inc. CFO Aaron Freidin Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589381700","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589381700?lang=en_us&edition=fundamental","pubTime":"2025-12-06 05:12","pubTimestamp":1764969178,"startTime":"0","endTime":"0","summary":"Aaron Freidin, Chief Financial Officer of Grail Inc., has reported a disposal of common shares of Grail Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL2Y8GZb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Grail Inc. CFO Aaron Freidin Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2588068862","title":"Grail Is Maintained at Equal-Weight by Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2588068862","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588068862?lang=en_us&edition=fundamental","pubTime":"2025-12-03 01:50","pubTimestamp":1764697800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GRAL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 02, 2025 12:50 ET (17:50 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2588103727","title":"Morgan Stanley Raises Price Target on GRAIL to $110 From $85, Keeps Equalweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2588103727","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588103727?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:47","pubTimestamp":1764676021,"startTime":"0","endTime":"0","summary":"Morgan Stanley Raises Price Target on GRAIL to $110 From $85, Keeps Equalweight Rating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2588670821","title":"Grail Grants RSUs to New Employees Under Inducement Equity Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2588670821","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588670821?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:01","pubTimestamp":1764622882,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. has granted restricted stock units  representing a total of 21,570 shares of its common stock to 21 recently hired non-executive employees. The RSUs will vest over approximately four years, with 25% vesting on November 30, 2026, and the remaining shares vesting in equal portions on each annual anniversary thereafter, contingent on continued employment with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via PR Newswire  on December 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL2Vjrsz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GRAL","BK4139"],"gpt_icon":0},{"id":"2588708284","title":"Grail Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588708284","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588708284?lang=en_us&edition=fundamental","pubTime":"2025-12-02 05:01","pubTimestamp":1764622860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nTUA3FJ0DX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2586442776","title":"Will GRAIL's (GRAL) Swift Capital Raise Redefine Its Approach to Funding Growth?","url":"https://stock-news.laohu8.com/highlight/detail?id=2586442776","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586442776?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:22","pubTimestamp":1764069760,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. recently completed a follow-on equity offering of US$300 million, following closely after filing a shelf registration for up to US$332.79 million in securities and reporting third quarter results.\nThis sequence of financing actions, occurring immediately after earnings showed narrowing net losses and increased revenue, underscores GRAIL's active efforts to strengthen its capital position as it pursues expanded growth initiatives.\nWe'll examine how GRAIL's move to quickly raise...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/will-grails-gral-swift-capital-raise-redefine-its-approach-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gral/grail/news/will-grails-gral-swift-capital-raise-redefine-its-approach-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"2584021995","title":"Illumina Reports Disposal of Grail Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584021995","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584021995?lang=en_us&edition=fundamental","pubTime":"2025-11-19 10:33","pubTimestamp":1763519607,"startTime":"0","endTime":"0","summary":"Illumina, Inc. has reported a disposal of common shares of Grail Inc., according to a recent SEC filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL6hj8HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4535","BK4121","BK4139","BK4548","BK4534","GRAL","ILMN"],"gpt_icon":0},{"id":"2584296563","title":"Grail Inc. to Present at Piper Sandler 37th Annual Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584296563","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584296563?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:02","pubTimestamp":1763499732,"startTime":"0","endTime":"0","summary":"Grail Inc., a healthcare company focused on early cancer detection, will present at the Piper Sandler 37th Annual Healthcare Conference on December 2. A live and replay webcast of the presentation will be available on the company's investor relations website.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grail Inc. published the original content used to generate this news brief via PR Newswire  on November 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL4ZfJ6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4127","BK4139","PIPR","GRAL"],"gpt_icon":0},{"id":"2584593009","title":"Grail falls -9.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584593009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584593009?lang=en_us&edition=fundamental","pubTime":"2025-11-18 23:06","pubTimestamp":1763478371,"startTime":"0","endTime":"0","summary":"Grail (GRAL) is down -9.3%, or -$7.94 to $77.00. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grail-falls-9-3-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grail-falls-9-3-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GRAL"],"gpt_icon":0},{"id":"1164255267","title":"Stock Track | GRAIL Soars 5.22% as Canaccord Genuity Maintains Buy Rating and Boosts Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=1164255267","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164255267?lang=en_us&edition=fundamental","pubTime":"2025-11-17 22:52","pubTimestamp":1763391166,"startTime":"0","endTime":"0","summary":"GRAIL, Inc. (GRAL) shares surged 5.22% in pre-market trading on Monday, following a positive analyst update from Canaccord Genuity. The biotechnology company, known for its innovative cancer...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GRAL"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":96,"code":"91000000","status":"200"}]}}